Clinical Trial Update: Remote Ischemic Preconditioning of Human Myocardium [Phase 2]

View source ↗

Summary

Phase 2 trial update on remote ischemic preconditioning of human myocardium in coronary artery bypass graft patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Bypass Graft Surgery
• Coronary Artery Disease

Snippet

Sponsor: Medical University of Silesia | Conditions: Coronary Artery Bypass Graft Triple Vessel, Apoptotic DNA Damage | Phase 2 | Status: COMPLETED